IL4I1 and diffuse large B-cell lymphoma: GSEA analysis on IL4I1 low vs. high patient GSE93984 (Figure 5C) confirmed that the loss of IL4I1 in DLBCL patients who received ibrutinib correlated with upregulation of TCA cycle enzymes.